|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Murine CD160, Ig-like receptor on NK cells and NKT cells, recognizes classical and nonclassical MHC class I and regulates NK cell activation显示文摘 | MAEDA M CARPENITO C RUSSELLI R C | 2005 | J Immunol2005，175，7： | 1 |
| 2 | Chimeric re- ceptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased anti- leukemic efficacy in vivo 显示文摘 | Milone M C Fish J D Carpenito C | 2009 | Molecular Therapy2009，17，8： | 1 |
| 3 | Chimeric receptors containing CD137 signal transduction domains mediate en- hanced survival of T cells and increased antileukemic efficacy in vivo显示文摘 | Milone MC Fish JD Carpenito C | 2009 | Mol Ther2009，17，8： | 1 |
| 4 | Chimeric receptors containing CDI37 siglal trantuction domains mediate enhanced survival of T cells and increased mltileukemic efficacy in vivo 显示文摘 | Milone M C Fish J D Carpenito C | 2009 | Mol Ther2009，17，8： | 1 |
| 5 | Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo显示文摘 | Mi:one MC Fish JD Carpenito C | 2009 | Mol Ther2009，17，8： | 1 |
| 6 | In vivo persistence, tumor localization, and antitumor activity of CAR engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB) 显示文摘 | Song DG Ye Q Carpenito C | 2011 | Cancer Res2011，71，13： | 1 |
| 7 | Murine CD160,Ig-like receptor on NK cells and NKT cells,recognizes classical and nonclassical MI-IC class I and regulates NK cell activation 显示文摘 | Maeda M Carpenito C Russell R | 2005 | J Immunol2005，175，7： | 1 |
| 8 | Chimeric receptors containing CD137 signal transduction domains mediate en hanced survival of T cells and increased antileukemic efficacy in vivo显示文摘 | Milone M C Fish J D Carpenito C | 2009 | MolTher2009，17，8： | 1 |
| 9 | The inducible costimulator ( ICOS ) is critical for the development of human T (H)17 ceils 显示文摘 | Paulos CM Carpenito C Plesa G | 2010 | Sci Transl Med2010，2，55： | 1 |
| 10 | Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo 显示文摘 | Milone MC Fish JD Carpenito C | 2009 | Mol Ther2009，17，8： | 1 |
| 11 | Control of large,established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains显示文摘 | Carpenito C Milone MC Hassan R | | 0，，： | 1 |
| 12 | Control of large, established tumor xenografts with genetically retargeted human T ceils containing CD28 and CD137 domains显示文摘 | Carpenito C Milone MC Hassan R | 2009 | Proc Natl Acad Sci U S A2009，106，9： | 1 |
| 13 | In vivo persistence, tumor lo- calization, and antitumor activity of CAR-engineered T ceils is en- hanced by costimulatory signaling through CD137 (4-1BB) 显示文摘 | Song DG Ye Q Carpenito C | 2011 | Cancer Res2011，71，13： | 1 |
| 14 | Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor显示文摘 | Zhao Y Moon E Carpenito C | 2010 | Cancer Res2010，70，22： | 1 |
| 15 | Control of large,established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains显示文摘 | Carpenito C Milone MC Hassan R | | 0，，： | 1 |
| 16 | Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo显示文摘 | MILONE M C FISH J D CARPENITO C | 2009 | Mol Ther2009，17，8： | 1 |
| 17 | Chimeric receptors containing CD137 signal transduetion domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo显示文摘 | Milone MC Fish JD Carpenito C | 2009 | Mol Ther2009，17，8： | 1 |
| 18 | Multiple injections of clectropo- rated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor显示文摘 | Zhao Y Moon E Carpenito C | 2010 | Cancer Res2010，70，22： | 1 |
| 19 | In vivo persistence, tumor lo-calization, and antitumoractivity of CAR-engineered T cells is enhanced bycostimulatory signaling through CD137 ( 4-1BB ) 显示文摘 | Song DG Ye Q Carpenito C | 2011 | Cancer Res2011，71，13： | 1 |
| 20 | In vivo persistence, tumor lo- calization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 ( 4-1BB ) 显示文摘 | Song DG Ye Q Carpenito C | 2011 | Cancer Res2011，71，13： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员